Web Results

www.jpml.uscourts.gov/sites/jpml/files/MDL-2706-Denied_Transfer-05-16.pdf

Jun 2, 2016 ... 2:14-00280. COOK v. WYETH PHARMACEUTICALS, INC., ET AL., C.A. No. 2:15- 00529. Northern District of California. COLLETTE v. WYETH ...

www.dailyreportingsuite.com/health/news/warnings_labeling_for_an_fda_approved_generic_drug_preempt_state_claims

Mar 13, 2018 ... Wyeth Pharmaceuticals, Inc., March 12, 2018, Donato, J.). ... (Unfair Competition Law or "UCL"), and the California Civil Code § 1750 et seq. ... generic drug manufacturer, noting that all of the patient's claims were framed under state ... Attorneys: Christopher W. Cantrell (Doyle APC) for Raymond J. Collette.

www.cell.com/current-biology/abstract/S0960-9822(14)00217-6?code=cell-site

Ziv Y. Burns L.D.; Cocker E.D.; Hamel E.O.; Ghosh K.K.; Kitch L.J.; El Gamal A. ... Nakazawa K. Quirk M.C.; Chitwood R.A.; Watanabe M. Yeckel M.F.; Sun L.D.; Kato A. Carr C.A.; Johnston D. Wilson M.A.; et al. .... Collett T.S.; Cartwright B.A.; Smith B.A. .... Etienne A.S.; Maurer R. Séguinot V. .... Stratton P. Wyeth G. Wiles J.

jeb.biologists.org/content/214/15/2474

(Domenici et al., 2011) is the issue of unpredictability both for directionality ... A major methodological issue: linear versus circular analysis of ETs ..... aim at specific targets when jumping voluntarily (Collett and Paterson, 1991; Eriksson, 1980). ..... and then drifting downstream (Wyeth and Willows, 2006; Wyeth et al., 2006).

bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-13-1229

Dec 24, 2013 ... Breivik et al.; licensee BioMed Central Ltd. 2013 ...... Gruenethal, Wyeth, Weifa, Bristol-Myers Squibb, ProStrakan, Orion, Nycomed, Jansen, ... Breivik H, Collett B , Ventafridda V, Cohen R, Gallacher D: Survey of chronic pain in ...

www.druganddevicelawblog.com/tag/scorecards

Judgment on the pleadings granted as to all generic defendants (some defendants' status as generic manufacturers was ...... Collette v. Wyeth Pharmaceuticals, Inc., 2018 WL 1258105 (N.D. Cal. ...... Wyeth et al., 562 F. Supp .2d 1056 (D. Minn.

clincancerres.aacrjournals.org/content/11/9/3353

May 1, 2005 ... Patients were stratified by ADT versus no ADT and EBRT alone versus EBRT with brachytherapy boost. ... were prepared from virus derived from the Wyeth ( New York City Board of Health) strain of vaccinia. .... Modification of the protocol described by Tsang et al. ..... Bolla M, Collette L, Blank L, et al.

journals.plos.org/plosone/article?id=10.1371/journal.pone.0043409

Sep 18, 2012 ... An ADAM-17 inhibitor is currently undergoing early clinical trials (Friedman et al., cancer research, meeting abstract). When testing different ...

www.ippractice.ca/litigation-statistics/intellectual-property-proceedings-in-federal-court-for-2016

T-60-16, ANDREW COLLETT v. NORTHLAND ART ... DEVELOPMENT INC. ET AL. v. MUNCHKIN, INC ET AL. Patent Infringement, 2016-01-22, Oslers; Smart & Biggar ...... T-2039-16, WYETH HOLDINGS LLC ET AL v. GLAXOSMITHKLINE ...